.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Orexin-A quantification in CSF is the clinical gold standard for diagnosing narcolepsy type 1 (NT1). However, traditional radioimmunoassays (RIA) often produce inaccurate results due to cross-reactivity and overestimation. Furthermore, this discrepancy has led to a long-standing conundrum regarding the presence of orexin in peripheral blood. Consequently, researchers have developed an optimized LC-MS/MS method that provides significantly higher sensitivity. Therefore, this method ensures superior diagnostic reliability for neurologists and sleep specialists.
Specifically, the new ultrasensitive method incorporates a streamlined one-step protein precipitation protocol. In addition, it utilizes acid-shielding and cocktail-protection strategies to mitigate enzymatic degradation. Moreover, the lower limit of quantification (LLOQ) reached an impressive 0.1 pg/mL. As a result, verification in paired CSF and blood samples revealed that orexin-B and peripheral orexins remain consistently below detection limits. Thus, this finding confirms that orexin is effectively absent from the peripheral blood of narcolepsy patients. Consequently, clinicians should continue to rely exclusively on CSF analysis for definitive biochemical diagnosis.
Moreover, the study demonstrates that the streamlined protocol reduces nonspecific adsorption. Therefore, this optimization makes the LC-MS/MS approach more practical for high-throughput clinical laboratories. Furthermore, identifying the absence of peripheral orexin simplifies the diagnostic algorithm. In contrast to older RIA techniques, this refined method eliminates the risk of false positives caused by peptide fragments. Finally, these advancements represent a significant step toward standardizing narcolepsy biomarkers globally.
LC-MS/MS offers much higher specificity and sensitivity. Unlike RIA, it avoids cross-reactivity with other proteins, ensuring more accurate Orexin-A quantification in CSF.
No, this optimized study confirms that orexin levels in peripheral blood remain below detection limits. Therefore, blood tests are currently not viable for narcolepsy diagnosis.
The method uses acid-shielding and a cocktail-protection strategy. These steps protect the peptide from enzymatic degradation and nonspecific adsorption, ensuring sample stability.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Always seek the advice of a qualified healthcare provider for any medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Cao Y et al. Tackling the Orexin Conundrum: An Optimized LC-MS/MS Method Demonstrates Accurate CSF Quantification and Absence in Peripheral Blood. Anal Chem. 2026 May 12. doi: 10.1021/acs.analchem.6c00454. PMID: 42118575.
Lindström M, et al. Orexin-A measurement in narcolepsy: A stability study and a comparison of LC-MS/MS and immunoassays. Clin Biochem. 2021 Apr;90:34-39. doi: 10.1016/j.clinbiochem.2021.01.009. PMID: 33539807.
Vialaret J, et al. 16-mer hypocretin-1/orexin-A in cerebrospinal fluid to diagnose narcolepsy. Sleep. 2025. doi: 10.1093/sleep/zsaf237. PMID: 40801283.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A study introduces an optimized LC-MS/MS method for accurate CSF Orexin-A quantification, resolving the conundrum of its presence in peripheral blood....
2 months ago
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
